Lv2
182 积分 2026-01-20 加入
How Effective is Chemoembolization (TACE) Compared to Standard Care on The Survival of Hepatoma Patients? A Systematic Review
3个月前
已关闭
Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma
3个月前
已完结
Hypoxia‑inducible factor‑1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma (Review)
3个月前
已完结
The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular Carcinoma
3个月前
已完结
Post-transarterial chemoembolization hypoxia-induced HIF-1α/WNT/β-catenin signaling promotes hepatocellular carcinoma progression via programed death ligand 1 upregulation
3个月前
已完结
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
3个月前
已完结
Global burden of primary liver cancer in 2020 and predictions to 2040
3个月前
已完结
Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field
3个月前
已完结
Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma
3个月前
已完结
Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysis
3个月前
已完结
皖公网安备34019202002308
